Yusuke Nagane
Nihon University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yusuke Nagane.
International Journal of Urology | 2010
Satoru Takahashi; Daisuke Obinata; Takahiro Sakuma; Yusuke Nagane; Katsuhiko Sato; Junichi Mochida; Taketo Ichinose; Kenya Yamaguchi
Objective: To prospectively evaluate the efficacy of a tension‐free vaginal mesh (TVM) procedure for pelvic organ prolapse (POP).
Urologia Internationalis | 2012
Daisaku Hirano; Yasuhiro Okada; Yusuke Nagane; K. Satoh; Junichi Mochida; Yataroh Yamanaka; Hitoshi Hirakata; Kenya Yamaguchi; Nozomu Kawata; Satoru Takahashi; Akihiro Henmi
Objectives: To elucidate clinicopathological risk factors for intravesical recurrence (IVR) in patients undergoing nephroureterectomy for upper urinary tract urothelial carcinoma (UUT-UC). Methods: We identified a study population of 151 consecutive patients without previous or concurrent bladder cancer who underwent nephroureterectomy for UUT-UC. IVR was assessed in relation to tumor location, size, and multifocality, operation modality and time, stage, grade, lymphovascular invasion, regional lymph node metastasis, preoperative urinary cytology, and perioperative chemotherapy. The median follow-up time was 24 months. Results: Of 151 patients, 51 (34%) developed IVR after nephroureterectomy, and 50 (98%) of the patients presented with IVR within 2 years. Tumor multifocality and site (located in ureter) were determined as risk factors for IVR by univariate analysis. In a multivariate analysis, only tumor multifocality (relative risk: 4.024, p = 0.001) was an independent predictor of IVR. Ten-year cancer-specific survival rates for the patients with and without IVR were 68 and 52%, respectively (p = 0.06). Conclusions: Tumor multifocality is a significant risk factor in developing IVR after surgery for UUT-UC. These results indicate that despite most IVR occurring within 2 years of treatment, it is necessary to follow such patients more closely using cystoscopy. However, IVR is unlikely to indicate a poorer prognosis.
International Journal of Urology | 2008
Nozomu Kawata; Yusuke Nagane; Kenya Yamaguchi; Taketo Ichinose; Hitoshi Hirakata; Satoru Takahashi
Aim: Symptomatic renal cell carcinoma (RCC) is well known to have a characteristic behavior. We therefore evaluated the impact of systemic symptoms on the prognosis of RCC.
Luts: Lower Urinary Tract Symptoms | 2010
Takahiro Sakuma; Katsuhiko Sato; Yusuke Nagane; Junichi Mochida; Shuji Sugimoto; Taketo Ichinose; Kenya Yamaguchi; Makoto Uchiyama; Satoru Takahashi
Objectives: We evaluated the association of lower urinary tract symptoms (LUTS) and sleep disorders (SD) in patients with benign prostatic hyperplasia (BPH). We also examined improvement of SD following the α1‐blocker therapy for LUTS.
Urology | 2007
Nozomu Kawata; Yusuke Nagane; Hitoshi Hirakata; Taketo Ichinose; Yasuhiro Okada; Kenya Yamaguchi; Satoru Takahashi
Urology | 2006
Nozomu Kawata; Yusuke Nagane; Takumi Igarashi; Hitoshi Hirakata; Taketo Ichinose; Takahiko Hachiya; Yukie Takimoto; Satoru Takahashi
International Urology and Nephrology | 2010
Daisaku Hirano; Yusuke Nagane; K. Satoh; Junichi Mochida; Shuji Sugimoto; Taketo Ichinose; Satoru Takahashi; Toshiya Maebayashi; Tsutomu Saitoh
International Journal of Clinical Oncology | 2010
Kenya Yamaguchi; Nozomu Kawata; Yusuke Nagane; Hiroshi Igarashi; Shuji Sugimoto; Hitoshi Hirakata; Satoru Takahashi; Tokio Higaki
The Journal of Urology | 2008
Kenya Yamaguchi; Nozomu Kawata; Yusuke Nagane; Takumi Igarashi; Taketo Ichinose; Hitoshi Hirakata; Yukie Takimoto; Satoru Takahashi
Hinyokika kiyo. Acta urologica Japonica | 2006
Nozomu Kawata; Takeo Ichinose; Takahiko Hachiya; Hitoshi Hirakata; Takumi Igarashi; Yusuke Nagane; Koutaro Morita; Yukie Takimoto
